Symmetry Partners, LLC Bio Techne Corp Transaction History

Symmetry Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 06, 2023	BUY	$80.67 - $352.29 $191,187 - $834,927	2,370 Added 300.0%	3,160 $262,000
Q4 2021 Jan 11, 2022	SELL	$456.15 - $525.06 $42,421 - $48,830	-93 Reduced 10.53%	790 $409,000
Q3 2021 Oct 18, 2021	BUY	$444.87 - $538.88 $54,719 - $66,282	123 Added 16.18%	883 $427,000
Q1 2021 May 03, 2021	SELL	$314.62 - $411.0 $943 - $1,233	-3 Reduced 0.39%	760 $290,000
Q4 2020 Feb 18, 2021	SELL	$246.9 - $321.87 $38,022 - $49,567	-154 Reduced 16.79%	763 $242,000
Q3 2020 Nov 03, 2020	BUY	$232.22 - $282.96 $212,945 - $259,474	917 New	917 $227,000
Q2 2019 Aug 07, 2019	SELL	$188.72 - $215.43 $74,544 - $85,094	-395 Closed	0 $0
Q4 2018 May 22, 2019	BUY	$132.75 - $203.8 $52,436 - $80,501	395 New	395 $57,000

616

156M

200K

15.3K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.59B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Symmetry Partners, LLC with notifications on news.